Extraintestinal manifestations (EIM) in inflammatory bowel disease (IBD) are frequent and
may occur before or after IBD diagnosis. EIM may impact the quality of life for patients with …

AIM: Advances in genetics and immunology have contributed to the current understanding of
the pathogenesis of inflammatory bowel diseases (IBD). METHODS: The current opinion on …

Extraintestinal manifestations of inflammatory bowel disease are prevalent in both ulcerative
colitis and Crohn's disease. The most common manifestations involve the musculoskeletal …

Methods: These guidelines are a joint effort of the European Crohn's and Colitis
Organization (ECCO) and the European Society of Paediatric Gastroenterology, Hepatology …

Colorectal cancer (CRC) is a heterogeneous disease, including at least three major forms:
hereditary, sporadic and colitis-associated CRC. A large body of evidence indicates that …

More than one-third of patients with IBD are affected by extraintestinal manifestations or
extraintestinal complications beyond the intestinal manifestation of the disease. The most …

Inflammatory bowel diseases (IBD) can be really considered to be systemic diseases since
they are often associated with extraintestinal manifestations, complications, and other …

Inflammatory gastrointestinal (GI) diseases and malignancies are associated with growing
morbidity and cancer-related mortality worldwide. GI tumor and inflammatory cells contain …

Increasing life expectancy in developed countries has led to a growing prevalence of
arthritic disorders, which has been accompanied by increasing prescriptions for nonsteroidal …

Background & Aims: It has been variably suggested that nonselective NSAIDs and
cyclooxygenase (COX)-2 selective inhibitors aggravate or ameliorate clinical disease activity …